Publications
Gu D, Cuby J, Gomez O, Mark H, Hall S, Stitzer M, Kushel M, Vijayaraghavan M. Money Helps: Financial Incentives for Smoking Cessation Among People Experiencing Homelessness. Substance use & misuse. 2026. PMID: 42246249
Harris CS, Tsai KK, Liu L, Oppegaard KR, Cooper BA, Paul SM, Hubbard EM, Levine JD, Miaskowski CA. Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma. Nursing research. 2026. PMID: 42228432
McConathy J, Koshkin VS, Menda Y, Rodon J, Goenka AH, Moy RH, Morse S, Demange A, Blumenstein L, Babaoglan B, Aimone P, Hope TA. Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42223513
Kennedy VE, Peretz CAC, Walia A, Chyla B, Sun Y, Hill JE, Tran E, Koh AD, Ferng TT, Pintar S, Jones M, Popescu B, Lomeli I, Chehab F, Murad N, John A, Roy RP, Olshen AB, Berryhill CA, Davis C, Angus SP, Rivera JM, Meshulam A, Stieglitz E, Joshi SK, Traer E, Dail M, Hamidi H, Altman JK, Daver NG, Levis MJ, McCloskey J, Perl AE, Smith CC. Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy. Blood. 2026. PMID: 42224378
Aggarwal R, Oseran AS, Manrai AK, Marinacci LX, Bhatt DL, Yeh RW, Ho JE, Rodman A, Wadhera RK. Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations. Circulation. 2026. PMID: 42224376
Beumer A, Carlson M, Arcuri AL, Maues J, Cowden J, Walker S, Shanahan K, Collins JL, Veach AJ, Rugo HS, Burkard ME, Kalinsky KM, Bardia A, Lustberg MB, Papautsky EL, Roberson ML. A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer. Journal of Patient Experience. 2026. PMID: 42227000
Malangwa G, Banzi MO, Makupa G, Nnko G, Mwakipunda L, Rugengemanzi E, Karia A, Ramadhan A, Mashashi G, Idrisa C, Gisiri M, Kashabano J, Mabruk NA, Moturi M, Mushi B, Ndumbalo J, Kahesa C, Maunda K, DeBoer RJ, Mmbaga E, Lugina EL. The social and clinical profile of patients with ocular surface squamous cell carcinoma in Tanzania. BMC cancer. 2026. PMID: 42218433
Dent S, Nadler MB, Blaes A, Iqbal A, Ayettey HNG, Alvarez-Cardona J, Chan A, Koh ES, Mascunano RC, George M, Aryeetey NA, Howden EJ, Kazuhiro S, Latif N, Ozaki AF, Semple CJ, Ramalingan T, Iyenger NM, Rugo HS, Koczwara B. Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026. PMID: 42209784
Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Research Communications. 2026. PMID: 42219553
Ramesh R, Osorio RC, Pekmezci M, Boreta L, Datta D, Alan N. Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case. World neurosurgery. 2026. PMID: 42214468
Hawes MR, Safier J, Clark B, Pamatmat M, Bonniot C, Cheng C, Almazar R, Gillece J, Vijayaraghavan M. Implementing Trauma-Informed Training for Tobacco Use for Health Care Professionals in Two California Counties. Health promotion practice. 2026. PMID: 42187031
Feng Z, Gu Y, Zheng W, Pu D, Liu J, Chen G, Liu D, Zhang X, Ye F, Zhang S, Ai W, Huang L, Yu Z, Zhou J, Zhou Y, Qin P, Fang H, Wang Z, Ke W. Mechanically Adaptive Viscoelastic Grain-Boundary Regulation in Blade-Coated Tin-Lead Perovskites. ACS applied materials & interfaces. 2026. PMID: 42183636
Duong N, Huynh DJ, Nikzad N, Kim WR, Shah N, Biggins SW, Kwong A. Reply: Validation of MELD 3.0 in 2 centers from different continents. Hepatology communications. 2026. PMID: 42172502
Asiimwe E, Hu D, Cheng J, Wu AHB, Kushi LH, Huang FW, Kachuri L, Oni-Orisan A, Ziv E. Clinical Implications of the Duffy-Null Genotype in Patients on Azathioprine or Methotrexate in the All of Us Cohort. The journal of applied laboratory medicine. 2026. PMID: 42168119
Boutin CA, Callegari M, Florescu D, Nguyen MH, Kaul D, Avery R, Chong P, Fisher C, Limaye AP, Clough L, Pergam SA, Green M, Michaels MG, Danziger-Isakov L, Angarone M, Keefer L, Daud A, Lorenzo-Redondo R, Tan M, Ison MG. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. PMID: 42177030
Motegi T, Huang F, Campbell JD. Benchmarking of local ancestry inference with different assays and parameters. bioRxiv : the preprint server for biology. 2026. PMID: 42239055
Allegakoen DV, Sahu PK, Kwong K, Morales J, Bivona TG, Sabnis AJ. The essential chaperone DNAJC17 activates HSP70 to coordinate RNA splicing and G2-M progression. Scientific Reports. 2026. PMID: 42156896
Jhaveri K, Rugo HS, Cortés J, Oliveira M, Howell SJ, Dalenc F, Gomez HL, Hu X, Krivorotko P, Loibl S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Zhukova L, Nardone A, Wadsworth I, D'Cruz C, Wantenaar T, Das D, de Bruin EC, Turner NC. Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42154572
Rosenberg JE, O'Donnell PH, Petrylak DP, Flaig TW, Hoimes CJ, Gupta S, Mar N, Friedlander TW, Tagawa ST, Bilen MA, Brown JR, McKay RR, Merchan JR, Srinivas S, Gorla S, Moreno BH, Davis G, Wirtz HS, Zhu Y, Milowsky MI. EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma. ESMO open. 2026. PMID: 42155320
Ginex PK, Thoele K, Ma Q, Searles Vitko A, Gathirua-Mwangi WG, Liepa AM, Panjic EH, Chou E, Ellis HJ, de Courcy J, Clewes C, Taraba J, Rugo HS. Care of Patients Receiving Abemaciclib: Results From Clinical Trials and a Healthcare Provider Survey. Clinical journal of oncology nursing. 2026. PMID: 42227802